# Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO)

> **NCT06038760** · — · TERMINATED · sponsor: **Ourotech, Inc.** · enrollment: 12 (actual)

## Conditions studied

- Brain Tumor
- Glioma, Malignant
- Ependymoma
- Oligodendroglioma
- Glioblastoma

## Interventions

- **PROCEDURE:** Resection

## Key facts

- **NCT ID:** NCT06038760
- **Lead sponsor:** Ourotech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2023-10-12
- **Primary completion:** 2024-12-01
- **Final completion:** 2025-07-25
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2025-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06038760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06038760, "Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06038760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*